Mutant huntingtin is present in neuronal grafts in huntington disease patients

Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice

Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563

Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in Brain

DiFiglia, M., Sapp, E., Chase, K. O., Davies, S. W., Bates, G. P., Vonsattel, J. P., & Aronin, N. (1997) · Science · doi:10.1126/science.277.5334.1990 · Cited by 2,439

Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation

Li, J.-Y., Englund, E., Holton, J. L., Soulet, D., Hagell, P., Lees, A. J., Lashley, T., Quinn, N. P., Rehncrona, S., Björklund, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1746 · Cited by 1,845

Huntington's disease: from molecular pathogenesis to clinical treatment

Ross, C. A., & Tabrizi, S. J. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70245-3 · Cited by 1,816

Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease

Kordower, J. H., Chu, Y., Hauser, R. A., Freeman, T. B., & Olanow, C. W. (2008) · Nature Medicine · doi:10.1038/nm1747 · Cited by 1,722

Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein

Desplats, P., Lee, H.-J., Bae, E.-J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E., & Lee, S.-J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903691106 · Cited by 1,485

Propagation of Tau Pathology in a Model of Early Alzheimer's Disease

de Calignon, A., Polydoro, M., Suárez-Calvet, M., William, C., Adamowicz, D. H., Kopeikina, K. J., Pitstick, R., Sahara, N., Ashe, K. H., Carlson, G. A., et al. (2012) · Neuron · doi:10.1016/j.neuron.2011.11.033 · Cited by 1,427

100 years of Lewy pathology

Goedert, M., Spillantini, M. G., Del Tredici, K., & Braak, H. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.242 · Cited by 1,190

The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription

Steffan, J. S., Kazantsev, A. G., Spasić-Bošković, O., Greenwald, M., Zhu, Y., Goehler, H., Wanker, E. E., Bates, G. P., Housman, D. E., & Thompson, L. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100110097 · Cited by 1,057

Trans-Synaptic Spread of Tau Pathology In Vivo

Liu, L., Drouet, V., Wu, J., Witter, M. P., Small, S. A., Clelland, C. L. T., & Duff, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031302 · Cited by 994

Connectomic imaging reveals Huntington‐related pathological and pharmaceutical effects in a mouse model

Chang, W., Puspitasari, F., Garcia‐Miralles, M., Yeow, L. Y., Tay, H. C., Koh, K. B., Tan, L. J., Pouladi, M. A., & Chuang, K. (2018) · NMR in Biomedicine · doi:10.1002/nbm.4007 · Cited by 21

Modeling of cumulative effects of time-varying drug exposures on within-subject changes in a continuous outcome

Danieli, C., Sheppard, T., Costello, R. E., Dixon, W. G., & Abrahamowicz, M. (2020) · Statistical Methods in Medical Research · doi:10.1177/0962280220902179 · Cited by 22

Inhibiting cellular uptake of mutant huntingtin using a monoclonal antibody: Implications for the treatment of Huntington's disease

Bartl, S., Oueslati, A., Southwell, A. L., Siddu, A., Parth, M., David, L. S., Maxan, A., Salhat, N., Burkert, M., Mairhofer, A., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104943 · Cited by 21

Use of adeno-associated virus-mediated delivery of mutant huntingtin to study the spreading capacity of the protein in mice and non-human primates

Maxan, A., Sciacca, G., Alpaugh, M., Zhu, T., Breger, L. S., Dehay, B., Zhang, L., Chuan, Q., Cisbani, G., Masnata, M., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104951 · Cited by 19

Binding, internalization and fate of H untingtin E xon1 fibrillar assemblies in mitotic and nonmitotic neuroblastoma cells

Ruiz-Arlandis, G., Pieri, L., Bousset, L., & Melki, R. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12258 · Cited by 21

Could astrocytes be the primary target of an offending agent causing the primary degenerative diseases of the human central nervous system? A hypothesis

Sica, R. E. P. (2015) · Medical Hypotheses · doi:10.1016/j.mehy.2015.02.004 · Cited by 18

Beyond Strains: Molecular Diversity in Alpha-Synuclein at the Center of Disease Heterogeneity

Wojewska, M. J., Otero‐Jimenez, M., Guijarro-Nuez, J., & Alegre‐Abarrategui, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713199 · Cited by 19

Regenerative medicine in Huntington's disease: Current status on fetal grafts and prospects for the use of pluripotent stem cell

Bachoud‐Lévi, A., & Perrier, A. L. (2014) · Revue Neurologique · doi:10.1016/j.neurol.2014.10.007 · Cited by 17

Prion-like properties of the mutant huntingtin protein in living organisms: the evidence and the relevance

Alpaugh, M., Denis, H. L., & Cicchetti, F. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01350-4 · Cited by 16

Huntingtin and Its Partner Huntingtin-Associated Protein 40: Structural and Functional Considerations in Health and Disease

Seefelder, M., Klein, F. A. C., Landwehrmeyer, G. B., Fernández‐Busnadiego, R., & Kochanek, S. (2022) · Journal of Huntington s Disease · doi:10.3233/jhd-220543 · Cited by 15

Investigational agents for the management of Huntington’s disease

Müller, T. H. (2016) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1270266 · Cited by 14

Prion-like mechanisms in neurodegenerative disease: Implications for Huntington’s disease therapy

Srinageshwar, B., Petersen, R. B., Dunbar, G. L., & Rossignol, J. (2020) · Stem Cells Translational Medicine · doi:10.1002/sctm.19-0248 · Cited by 14

Rhes Tunnels: A Radical New Way of Communication in the Brain's Striatum?

Subramaniam, S. (2020) · BioEssays · doi:10.1002/bies.201900231 · Cited by 15

N-terminal mutant huntingtin deposition correlates with CAG repeat length and symptom onset, but not neuronal loss in Huntington's disease

Layburn, F., Tan, A. Y. S., Mehrabi, N. F., Curtis, M. A., Tippett, L. J., Turner, C. P., Riguet, N., Aeschbach, L., Lashuel, H. A., Dragunow, M., et al. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105884 · Cited by 15

Small, Seeding-Competent Huntingtin Fibrils Are Prominent Aggregate Species in Brains of zQ175 Huntington’s Disease Knock-in Mice

Schindler, F., Praedel, N., Neuendorf, N., Kunz, S., Schnoegl, S., Mason, M. A., Taxy, B. A., Bates, G., Khoshnan, A., Priller, J., et al. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.682172 · Cited by 11

Tau: A Common Denominator and Therapeutic Target for Neurodegenerative Disorders

Maxan, A., & Cicchetti, F. (2018) · Journal of Experimental Neuroscience · doi:10.1177/1179069518772380 · Cited by 14

Molecular Mechanisms Mediating the Transfer of Disease-Associated Proteins and Effects on Neuronal Activity

Brás, I. C., Khani, M. H., Vasili, E., Möbius, W., Riedel, D., Parfentev, I., Gerhardt, E., Fahlbusch, C., Urlaub, H., Zweckstetter, M., et al. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223516 · Cited by 18

Role of TFEB in Huntington’s Disease

Ojalvo-Pacheco, J., Yakhine-Diop, S. M. S., Fuentes, J. M., Paredes-Barquero, M., & Niso‐Santano, M. (2024) · Biology · doi:10.3390/biology13040238 · Cited by 12

Cysteine String Protein Controls Two Routes of Export for Misfolded Huntingtin

Pink, D., Donnelier, J., Lewis, J. D., & Braun, J. E. A. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.762439 · Cited by 12

The Complexity of Clinical Huntington’s Disease: Developments in Molecular Genetics, Neuropathology and Neuroimaging Biomarkers

Tippett, L. J., Waldvogel, H. J., Snell, R. G., Vonsattel, J., Young, A. B., & Faull, R. L. M. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-57193-5_5 · Cited by 12

Gene therapy and immunotherapy as promising strategies to combat Huntington’s disease-associated neurodegeneration: emphasis on recent updates and future perspectives

Jamwal, S., Elsworth, J. D., Rahi, V., & Kumar, P. (2020) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1801424 · Cited by 12

Striatal Induction and Spread of the Huntington’s Disease Protein: A Novel Rhes Route

Subramaniam, S. (2022) · Journal of Huntington s Disease · doi:10.3233/jhd-220548 · Cited by 12

Restoring Function to Dopaminergic Neurons: Progress in the Development of Cell-Based Therapies for Parkinson’s Disease

Henchcliffe, C., & Sarva, H. (2020) · CNS Drugs · doi:10.1007/s40263-020-00727-3 · Cited by 11

Emerging roles of extracellular vesicles in polyglutamine diseases: Mutant protein transmission, therapeutic potential, and diagnostics

Takeuchi, T., & Nagai, Y. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105357 · Cited by 10

Exploring Exosome-Based Approaches for Early Diagnosis and Treatment of Neurodegenerative Diseases

Varshney, V., Gabble, B. C., Bishoyi, A. K., Varma, P., Qahtan, S. A., Kashyap, A., Panigrahi, R., Nathiya, D., & Chauhan, A. S. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05026-w · Cited by 10

Revisiting cell and gene therapies in Huntington’s disease

Beatriz, M., Lopes, C., Ribeiro, A. C., & Rego, A. C. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24845 · Cited by 12

A brief history of antibody-based therapy

Alpaugh, M., & Cicchetti, F. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104504 · Cited by 10

Indications and prospects of neural transplantation for chronic neurological diseases

Vadori, M., Denaro, L., D’Avella, D., & Cozzi, E. (2016) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000344 · Cited by 9

Challenges in progressing cell therapies to the clinic for Huntington's disease: A review of the progress made with pluripotent stem cell derived medium spiny neurons

Jareño, P. G., Bartley, O. J. M., Precious, S. V., Rosser, A., & Lelos, M. J. (2022) · International review of neurobiology · doi:10.1016/bs.irn.2022.09.003 · Cited by 9

Reducing huntingtin by immunotherapy delays disease progression in a mouse model of Huntington disease

Bartl, S., Xie, Y., Potluri, N., Kesineni, R., Hencak, K., Cengio, L. D., Balazs, K., Oueslati, A., Parth, M., Salhat, N., et al. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106376 · Cited by 8

Extracellular Vesicles Physiological Role and the Particular Case of Disease-Spreading Mechanisms in Polyglutamine Diseases

Moreira, R., Mendonça, L. S., & de Almeida, L. P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212288 · Cited by 7

Intracellular and intercellular transport of RNA organelles in CXG repeat disorders: The strength of weak ties

Nabariya, D. K., Heinz, A., Derksen, S., & Krauß, S. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1000932 · Cited by 9

The long noncoding RNA nHOTAIRM1 is necessary for differentiation and activity of iPSC-derived spinal motor neurons

Tollis, P., Vitiello, E., Migliaccio, F., D’Ambra, E., Rocchegiani, A., Garone, M. G., Bozzoni, I., Rosa, A., Carissimo, A., Laneve, P., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06196-y · Cited by 8

The Potential of Alternate Sources of Cells for Neural Grafting in Parkinson’s and Huntington’s Disease

Drouin‐Ouellet, J. (2014) · Neurodegenerative Disease Management · doi:10.2217/nmt.14.26 · Cited by 9

Reactive astrocytes promote proteostasis in Huntington’s disease through the JAK2-STAT3 pathwayPreprint

Abjean, L., Haim, L. B., Riquelme‐Perez, M., Gipchtein, P., Derbois, C., Palomares, M.-A., Petit, F., Hérard, A., Gaillard, M., Guillermier, M., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.29.441924 · Cited by 10

Brain–Periphery Interactions in Huntington’s Disease: Mediators and Lifestyle Interventions

Burtscher, J., Strasser, B., Pepe, G., Burtscher, M., Kopp, M., Pardo, A. D., Maglione, V., & Khamoui, A. V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094696 · Cited by 8

Possible Role of the Polyglutamine Elongation in Evolution of Amyloid-Related Evolvability

Hashimoto, M., Ho, G. J., Takamatsu, Y., Wada, R., Sugama, S., Takenouchi, T., Masliah, E., & Waragai, M. (2018) · Journal of Huntington s Disease · doi:10.3233/jhd-180309 · Cited by 7

Structural insight into transmissive mutant huntingtin species by correlative light and electron microscopy and cryo-electron tomography

Kuang, X., Nunn, K., Jiang, J. B., Castellano, P., Hardikar, U., Horgan, A., Kong, J., Tan, Z., & Dai, W. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.04.124 · Cited by 7

Common molecular mechanisms underlie the transfer of alpha-synuclein, Tau and huntingtin and modulate spontaneous activity in neuronal cellsPreprint

Brás, I. C., Khani, M., Vasili, E., Möbius, W., Riedel, D., Parfentev, I., Gerhardt, E., Fahlbusch, C., Urlaub, H., Zweckstetter, M., et al. (2021) · bioRxiv · doi:10.1101/2021.07.18.452825 · Cited by 3

A method for the analysis of the oligomerization profile of the Huntington’s disease-associated, aggregation-prone mutant huntingtin protein by isopycnic ultracentrifugation

Bonavita, R., Martino, R. D., Cortone, G., Prodomo, A., Gennaro, M. D., Scerra, G., Panico, V. J. A., Nuzzo, S., Salvatore, M., Williams, S. V., et al. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1420691 · Cited by 6

Detection of antibodies against the huntingtin protein in human plasma

Denis, H. L., Alpaugh, M., Alvarez, C., Fenyi, A., Barker, R. A., Chouinard, S., Arrowsmith, C. H., Melki, R., Labib, R., Harding, R., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04687-x · Cited by 6

Deep brain stimulation and stereotactic-assisted brain graft injection targeting fronto-striatal circuits for Huntington’s disease: an update

Kinfe, T. M., Vecchio, A. D., Nüssel, M., Zhao, Y., Stadlbauer, A., & Buchfelder, M. (2022) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2022.2091988 · Cited by 5

Evidence of mutant huntingtin and tau-related pathology within neuronal grafts in Huntington’s disease cases

Salem, S., Kilgore, M. D., Anwer, M., Maxan, A., Child, D. D., Bird, T. D., Keene, C. D., Cicchetti, F., & Latimer, C. S. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106542 · Cited by 5

Exploring immunotherapeutic strategies for neurodegenerative diseases: a focus on Huntington’s disease and Prion diseases

Mukherjee, A., Biswas, S., & Roy, I. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01455-w · Cited by 5

Elucidating cortical neurovascular involvement in Huntington's disease using human brain tissue microarrays

Tan, A. Y. S., Martinez, L. C. M. G., Murray, H. C., Mehrabi, N. F., Tippett, L. J., Turner, C. P., Curtis, M. A., Faull, R. L. M., Dragunow, M., & Singh‐Bains, M. K. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106829 · Cited by 5

Survival of iPSC-derived grafts within the striatum of immunodeficient mice: Importance of developmental stage of both transplant and host recipient

Tom, C. M., Younesi, S., Meer, E. A., Bresee, C. J., Godoy, M. I., & Mattis, V. B. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.07.018 · Cited by 5

The troubling story of blood-driven dementias

Rieux, M., Alpaugh, M., & Cicchetti, F. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0225-z · Cited by 5

The Evolving Landscape of Stem Cell Therapies for Huntington’s Disease

Estarellas, M., Gomis, C., & Canals, J. M. (2025) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-025-00816-3 · Cited by 4

Disease-Modification in Huntington’s Disease: Moving Away from a Single-Target Approach

Jensen, M. P., & Barker, R. A. (2019) · Journal of Huntington s Disease · doi:10.3233/jhd-180320 · Cited by 4

Rewiring Neuroimmunity: Nanoplatform Innovations for CNS Disease Therapy

Akbar, M. U., Guo, W., Shen, X. M., Fang, Y., Liu, Y., Wang, P., Elnathan, R., & Chen, Y. (2025) · Advanced Therapeutics · doi:10.1002/adtp.202500124 · Cited by 3

Something wicked this way comes: huntingtin

Spada, A. R. L. (2014) · Nature Neuroscience · doi:10.1038/nn.3770 · Cited by 3

Understanding the role of the hematopoietic niche in Huntington's disease's phenotypic expression: in vivo evidence using a parabiosis model

Rieux, M., Alpaugh, M., Salem, S., Siddu, A., Saint‐Pierre, M., Denis, H. L., Rohweder, H., Herrmann, F., Bazenet, C. E., Lacroix, S., et al. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106091 · Cited by 3

Extracellular Vesicles as Possible Sources of Huntington’s Disease Biomarkers

Ananbeh, H., & Skalníková, H. K. (2023) · Contemporary clinical neuroscience · doi:10.1007/978-3-031-32815-2_3 · Cited by 3

Pluripotent Stem Cells to Model and Treat Huntington’s Disease

Wenceslau, C. V., Kerkis, I., Pompéia, C., & Haddad, M. S. (2017) · InTech eBooks · doi:10.5772/66589 · Cited by 2

The multitude of therapeutic targets in neurodegenerative proteinopathies

Melki, R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805120-7.00001-4 · Cited by 3

Prion-Like Propagation in Neurodegenerative Diseases

Peelaerts, W., Baekelandt, V., & Brundin, P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811304-2.00008-0 · Cited by 3

Long-Term Engraftment of Cryopreserved Human Neurons for In Vivo Disease Modeling in Neurodegenerative Disease

Marmion, D. J., Deng, P., Hiller, B. M., Lewis, R. L., Harms, L. J., Cameron, D. L., Nolta, J. A., Kordower, J. H., Fink, K. D., & Wakeman, D. R. (2025) · Biology · doi:10.3390/biology14020217 · Cited by 2

Autophagy–exosome crosstalk in neurodegeneration: Mechanisms and therapeutic opportunities

Sedighi, S., Guan, T., Michetti, F., Cordani, M., Behrooz, A. B., Sabouni, F., Eshraghi, M., Saleem, A., Ghavami, S., & Aghanoori, M. (2026) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2026.109025 · Cited by 3

Mixed longitudinal and cross-sectional analyses of deep gray matter and white matter using diffusion weighted images in premanifest and manifest Huntington’s disease

Hu, B., Laurent Younes, B., Bu, X., Liu, C.-F., Ratnanather, J. T., Paulsen, J. S., Georgiou‐Karistianis, N., Miller, M. I., Ross, C. A., & Faria, A. V. (2023) · NeuroImage Clinical · doi:10.1016/j.nicl.2023.103493 · Cited by 2

Lipid Metabolism: Key Determinant in Neurodegenerative Diseases

Yadav, M., Gupta, J., & Agrawal, N. (2024) · Springer eBooks · doi:10.1007/978-981-97-4288-2_6 · Cited by 2

Huntington’s disease

McGarry, A. J., Biglan, K., & Marshall, F. J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19176-3.00012-1 · Cited by 2

Misfolded proteins in H untington disease fetal grafts: Further evidence of cell‐to‐cell transfer?

Kordower, J. H., & Halliday, G. M. (2014) · Annals of Neurology · doi:10.1002/ana.24205 · Cited by 2

Movement disorders: discoveries in pathophysiology and therapy

Berg, D., & Deuschl, G. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70307-2 · Cited by 2

FACULTE MIXTE DE MEDECINE ET DE PHARMACIE DE ROUEN

Eltchaninoff, H., Lacroix, D., & Savoure, D. A. (2013) · Cited by 2

From huntingtin gene to Huntington’s disease-altering strategies

Déglon, N. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805120-7.00010-5 · Cited by 4

Curbing Rhes Actions: Mechanism-based Molecular Target for Huntington’s Disease and Tauopathies

Subramaniam, S., & Boregowda, S. V. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230320103518 · Cited by 3

Cargo-Loading of Misfolded Proteins into Extracellular Vesicles: The CSPα-EV Export PathwayPreprint

Pink, D., Donnelier, J., Lewis, J., & Braun, J. E. A. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/310219 · Cited by 2

Rhes protein transits from neuron to neuron and facilitates mutant huntingtin spreading in the brainPreprint

Ramírez-Jarquín, U. N., Sharma, M., Shahani, N., Li, Y., Boregowda, S., & Subramaniam, S. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.27.457956 · Cited by 2

Extracellular vesicles as paradigm shifters: Transformative roles in diagnosis and therapy for brain disorders

Puthiyattil, N., Varughese, D., Mani, B. M., Babu, R. S., Nair, K. S., George, R. L., Ramitha, P. A., Dogra, N., Mathew, M., Varghese, M. T., et al. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103178 · Cited by 2

Huntington disease

Jankovic, J. J., Hallett, M., Okun, M. S., Comella, C., Fahn, S., & Goldman, J. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-31071-0.00013-5 · Cited by 1

Mutant huntingtin oligomers drive early human pathogenesis in Huntington’s diseasePreprint

Miguez, A., Gomis, C., Vila, C., Tortajada, M., Fernández‐García, S., Bombau, G., Galofré, M., Garcı́a-Bravo, M., Sanders, P., Fernández-Medina, H., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-2154496/v1 · Cited by 1

Maladie de Huntington à début tardif à propos d'une série de 23 cas

Rouillé, A. (2015) · HAL

In vivo progressive degeneration of Huntington’s disease patient-derived neurons reveals human-specific pathological phenotypesPreprint

Miguez, A., Fernández‐García, S., Tortajada, M., Bombau, G., Galofré, M., Garcı́a-Bravo, M., Vila, C., Sanders, P., Fernández-Medina, H., Poquet, B., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.21.347062

The effect of nucleic acid-binding ligands on CTG/CAG repeat DNA metabolism in vitro

Chiang, K. (2018) · TSpace (University of Toronto)

Systematic comparison of the molecular mechanisms underlying the spreading of pathology in different neurodegenerative diseases

Brás, I. C. (2021) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8891

N-terminal mutant Huntingtin deposition correlates with CAG repeat length and disease onset, but not neuronal loss in Huntington’s diseasePreprint

Layburn, F. E., Tan, A. Y. S., Mehrabi, N. F., Curtis, M. A., Tippett, L. J., Riguet, N., Aeschbach, L., Lashuel, H. A., Dragunow, M., Faull, R. L. M., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.03.490349

3-6 Yaş Arası Çocukların Annelerinin Kendi Çocuğunu Duygusal İstismar Etme Potansiyeli ile Çocukluk Travmaları Arasındaki İlişkinin Yapısal Eşitlik Modeli ile İncelenmesi

ALPTEKİN, A. (2022) · The Journal of International Educational Sciences · doi:10.29228/inesjournal.66687

Functional and Physiological MRI Measures as Early Biomarkers for Huntington’s Disease

Duan, W. (2023) · Contemporary clinical neuroscience · doi:10.1007/978-3-031-32815-2_7

Additional file 2 of The blood-brain barrier is disrupted in Machado-Joseph disease/spinocerebellar ataxia type 3: evidence from transgenic mice and human post-mortem samples

Lobo, D. D., Nobre, R. J., Oliveira Miranda, C., Pereira, D., Castelhano, J., Sereno, J., Koeppen, A. H., Castelo-Branco, M. S., & Pereira de Almeida, L. (2020) · Figshare · doi:10.6084/m9.figshare.12900661

Additional file 1 of The blood-brain barrier is disrupted in Machado-Joseph disease/spinocerebellar ataxia type 3: evidence from transgenic mice and human post-mortem samples

Lobo, D. D., Nobre, R. J., Oliveira Miranda, C., Pereira, D., Castelhano, J., Sereno, J., Koeppen, A. H., Castelo-Branco, M. S., & Pereira de Almeida, L. (2020) · Figshare · doi:10.6084/m9.figshare.12900658

Binding and internalization of exogenous protein assemblies by mammalian cells

Ruiz-Arlandis, G. (2015) · theses.fr (ABES) · doi:10.70675/437e0532ze4e1z4966z80e5z340b6fd3c49d

Les astrocytes réactifs, des partenaires anti-agrégants dans la maladie de Huntington : identification des mécanismes impliqués dans le dialogue neurone-astrocyte

Abjean, L. (2019) · theses.fr (ABES) · doi:10.70675/f664e003zf93fz467eza6a3z3d953eaffe4e

Development of Inhibitors of Amyloid Fibril Propagation

Bendifallah, M. (2019) · theses.fr (ABES) · doi:10.70675/a872e5bdzc153z41f4z9472z725fd78aab48

Implication physio-pathologique de l'axe de signalisation PrPC-ADAM10/17 : des maladies neurodégénératives aux cancers

Bizingre, C. (2024) · theses.fr (ABES) · doi:10.70675/41caa2ebzce2bz41f1za34azee35192fd4bb

Investigating the molecular signature of reactive astrocytes mediated by the JAK2- STAT3 pathway using different omics : transcriptomics and proteomics insights

Riquelme‐Perez, M. (2023) · theses.fr (ABES) · doi:10.70675/72aad0d8z36a8z4a7azb1eaze65fa79463da

Functional impacts of Huntingtin lowering on the synaptic maturation and activity of neuronal networks derived from human induced pluripotent stem cells

Louçã, M. (2024) · theses.fr (ABES) · doi:10.70675/f5800d08zd8f4z4fbdz9043za4bde4fa031a

Exosomes in Amyloid Propagation—Roles in Neurodegeneration

Mishra, R., & Upadhyay, A. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05913-w

Mutant huntingtin in the extracellular matrix: A new perspective on Huntington's disease pathology

Trabolsi, C., & Cicchetti, F. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107502

Extracellular vesicles in neurodegenerative diseases: A new frontier in diagnosis and therapy

Mohammad, S. I., Vasudevan, A., Oriquat, G., Gajjar, T. B., Hanumanthayya, M., Shukla, S. K., Tailor, N. K., Baig, M. R., Fadaam, O., & Abdul, A. S. (2026) · Behavioural Brain Research · doi:10.1016/j.bbr.2026.116455

α-Synuclein Seeding in Dopaminergic Neurons Transplanted into the Putamen of Parkinson’s Disease PatientsPreprint

Duvernay, J. B., Killinger, B. A., Choi, S. G., Tittle, T., Bahrami, A., Tharp, M. E., Mercado, G., Chu, Y., Brundin, P., & Kordower, J. H. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.22.751740

From patient cells to patient therapy: Twenty years of iPSC-based translation in neurodegenerative disease

Cha, Y., & Kim, K. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.103104

Extracellular Vesicles and Exosomes as Biomarkers in Huntington’s Disease: Uncovering Pathogenic Insights and Pioneering Therapies

Vafadar, A., Shaghaghian, D., Charami, H., Hadinia, F., Didehdar, D., Movahedpour, A., & Ehtiati, S. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06205-z

When brain networks crash: connectivity, slow-wave activity and neural replay in Alzheimer's disease

Pini, L., Campuzano, C., Zhang, L., Imbimbo, B. P., & Allegra, M. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.107053

S4‐02‐01: Can the mutant huntingtin gene product spread from cell to cell? Evidence from neuronal allografts in huntington's disease patients

Cicchetti, F. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.07.325

Can the mutant huntingtin gene product spread from cell to cell: Evidence from neuronal allografts in Huntington's disease patients (S15.002)

Cicchetti, F., Lacroix, S., Cisbani, G., Vallières, N., Saint‐Pierre, M., St‐Amour, I., Tolouei, R., Skepper, J. N., Hauser, R. A., Mantovani, D., et al. (2015) · Neurology · doi:10.1212/wnl.84.14_supplement.s15.002 · Cited by 1

Mutant huntingtin can spread to allografted neurons in patients with Huntington disease

(2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.95

Evidence of mutant huntingtin and tau-related pathology within neuronal grafts in Huntington’s disease cases

Salem, S., Kilgore, M. D., Anwer, M., Maxan, A., Child, D. D., Bird, T. D., Keene, C. D., Cicchetti, F., & Latimer, C. S. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106542 · Cited by 5

Transneuronal propagation of mutant huntingtin contributes to non–cell autonomous pathology in neurons

Pecho‐Vrieseling, E., Rieker, C., Fuchs, S., Bleckmann, D., Esposito, M. S., Botta, P., Goldstein, C., Bernhard, M., Galimberti, I., Müller, M. M., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3761 · Cited by 193